Federal Register / Vol. 73, No. 3 / Friday, January 4, 2008 / Notices 873 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meetings 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of meetings of the 

National Cancer Institute Clinical Trials 

Advisory Committee. 

The meetings will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: National Cancer 

Institute Clinical Trials Advisory Committee, 

Ad Hoc Coordination Subcommittee. 

Date: February 3, 2008. 

Time: 7 p.m. to 9 p.m. 

Agenda: Discussion of the harmonization 

of SPORE, Cancer Center, and Cooperative 

Group Guidelines. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Sheila A. Prindiville, MD., 

Director, Coordinating Center for Clinical 

Trials, Office of the Director, National Cancer 

Institute, National Institutes of Health, 6120 

Executive Blvd., Suite 507, Bethesda, MD 

20892, 301–451–5048, 

prindivs@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Clinical Trials Advisory Committee. 

Date: February 4, 2008. 

Time: 8 a.m. to 12 p.m. 

Agenda: Update on the progress of the 

implementation of the Clinical Trials 

Working Group. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, 6th Floor, 

Conference Room 10, Bethesda, MD 20892. 

Contact Person: Sheila A. Prindiville, MD., 

Director, Coordinating Center for Clinical 

Trials, Office of the Director, National Cancer 

Institute, National Institutes of Health, 6120 

Executive Blvd., Suite 507, Bethesda, MD 

20892, 301–451–5048, 

prindivs@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 26, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–6270 Filed 1–3–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of meetings of the 

National Advisory Research Resources 

Council. 

The meetings will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Research Resources Council. 

Date: January 30, 2008. 

Open: 8 a.m. to 1:40 p.m. 

Agenda: Report of the Director, NCRR, 

reports by four of the NPRC Directors, and 

other business of the Council. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Floor 6C, 

Conference Room 6, Bethesda, MD 20892. 

Closed: 1:40 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Floor 6C, 

Conference Room 6, Bethesda, MD 20892. 

Contact Person: Louise E. Ramm, PhD, 

Deputy Director, National Center for 

Research Resources, National Institutes of 

Health, Building 31, Room 3B11, Bethesda, 

MD 20892, 301–496–6023, 

louiser@ncrr.nih.gov. 

Name of Committee: National Advisory 

Research Resources Council. 

Date: May 14, 2008. 

Open: 8 a.m. to 1:30 p.m. 

Agenda: Report of the Director, NCRR and 

other Council business. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Floor 6C, 

Conference Room 10, Bethesda, MD 20892. 

Closed: 1:40 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Floor 6C, 

Conference Room 10, Bethesda, MD 20892. 

Contact Person: Louise E. Ramm, PhD, 

Deputy Director, National Center for 

Research Resources, National Institutes of 

Health, Building 31, Room 3B11, Bethesda, 

MD 20892, 301–496–6023, 

louiser@ncrr.nih.gov. 

Name of Committee: National Advisory 

Research Resources Council. 

Date: September 16, 2008. 

Open: 8 a.m. to 1:30 p.m. 

Agenda: Report of the Director, NCRR and 

other Council business. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Floor 6C, 

Conference Room 10, Bethesda, MD 20892. 

Closed: 1:40 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Floor 6C, 

Conference Room 10, Bethesda, MD 20892. 

Contact Person: Louise E. Ramm, PhD, 

Deputy Director, National Center for 

Research Resources, National Institutes of 

Health, Building 31, Room 3B11, Bethesda, 

MD 20892, 301–496–6023, 

louiser@ncrr.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.ncrr.nih.gov/newspub/minutes.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 


jlentini on PROD1PC65 with NOTICES